|
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
|
07 October 2020 |
|
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
|
23 September 2020 |
|
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
|
31 August 2020 |
|
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
|
04 August 2020 |
|
GSK and CureVac announce strategic mRNA technology collaboration
|
21 July 2020 |
|
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
|
07 July 2020 |
|
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials
|
25 June 2020 |
|
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
|
20 April 2020 |
|
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
|
08 April 2020 |
|
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
|
03 March 2020 |